Mount Sinai Hospital (MSH)


Toronto, Canada

Publications in cooperation with FAU scientists

Go to first page Go to previous page 1 of 4 Go to next page Go to last page
Awadalla, M., Golden, D.L.A., Mahmood, S.S., Alvi, R.M., Mercaldo, N.D., Hassan, M.Z.O.,... Neilan, T.G. (2019). Influenza vaccination and myocarditis among patients receiving immune checkpoint inhibitors. Journal for ImmunoTherapy of Cancer, 7.
Jain, P., Finger, P.T., Damato, B., Coupland, S.E., Heimann, H., Kenawy, N.,... Yin, V. (2019). Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma. JAMA Ophthalmology, 137(8), 905-911.
Dork, T., Peterlongo, P., Mannermaa, A., Bolla, M.K., Wang, Q., Dennis, J.,... Geisler, J. (2019). Two truncating variants in FANCC and breast cancer risk. Scientific Reports, 9(1).
Pavel, M.E., Cwikla, J., Wolin, E., Phan, A., Raderer, M., Sedlackova, E.,... Caplin, M. (2018). Final analysis of time to subsequent disease progression/death in patients with metastatic enteropancreatic neuroendocrine tumours progressing under placebo and switched to lanreotide Autogel/depot 120mg in the CLARINET open-label extension. (pp. 310-310).
Anderson, N.D., De Borja, R., Young, M.D., Fuligni, F., Rosic, A., Roberts, N.D.,... Shlien, A. (2018). Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors. Science, 361(6405).
De Boer, N.K.H., Peyrin-Biroulet, L., Jharap, B., Sanderson, J.D., Meijer, B., Atreya, I.,... Neurath, M. (2018). Thiopurines in Inflammatory Bowel Disease: New Findings and Perspectives. Journal of Crohns & Colitis, 12(5), 610-620.
Haycock, P.C., Burgess, S., Nounu, A., Zheng, J., Okoli, G.N., Bowden, J.,... Smith, G.D. (2017). Association Between Telomere Length and Risk of Cancer and Non-Neoplastic Diseases: A Mendelian Randomization Study. JAMA Oncology, 3(5), 636-651.
Guo, Q., Burgess, S., Turman, C., Bolla, M.K., Wang, Q., Lush, M.,... Pharoah, P.D.P. (2017). Body mass index and breast cancer survival: a Mendelian randomization analysis. International Journal of Epidemiology, 46(6), 1814-1822.
Shimelis, H., Mesman, R.L.S., Von Nicolai, C., Ehlen, A., Guidugli, L., Martin, C.,... Couch, F.J. (2017). BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. Cancer Research, 77(11), 2789-2799.
Taylor, C.A., Gaur, S., Leipsic, J., Achenbach, S., Berman, D.S., Jensen, J.M.,... Norgaard, B.L. (2017). Effect of the ratio of coronary arterial lumen volume to left ventricle myocardial mass derived from coronary CT angiography on fractional flow reserve. Journal of Cardiovascular Computed Tomography, 11(6), 429-436.
Jiao, X., Aravidis, C., Marikkannu, R., Rantala, J., Picelli, S., Adamovic, T.,... Lindblom, A. (2017). PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. Oncotarget, 8(61), 102769-102782.
Brouckaert, O., Rudolph, A., Laenen, A., Keeman, R., Bolla, M.K., Wang, Q.,... Neven, P. (2017). Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study. Breast Cancer Research, 19(1).
Fagerholm, R., Khan, S., Schmidt, M.K., Garcia-Closas, M., Heikkila, P., Saarela, J.,... Nevanlinna, H. (2017). TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer. Oncotarget, 8(11), 18381-18398.
Schmidt, M.K., Hogervorst, F., Van Hien, R., Cornelissen, S., Broeks, A., Adank, M.A.,... Easton, D.F. (2016). Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. Journal of Clinical Oncology, 34(23), 2750-60.
Wyszynski, A., Hong, C.-C., Lam, K., Michailidou, K., Lytle, C., Yao, S.,... Cole, M.D. (2016). An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Human Molecular Genetics, 25(17), 3863-3876.
Hampras, S.S., Sucheston-Campbell, L.E., Cannioto, R., Chang-Claude, J., Modugno, F., Doerk, T.,... Moysich, K.B. (2016). Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget.
Hamdi, Y., Soucy, P., Adoue, V., Michailidou, K., Canisius, S., Lemacon, A.,... Simard, J. (2016). Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. Oncotarget, 7(49), 80140-80163.
Zhao, Z., Wen, W., Michailidou, K., Bolla, M.K., Wang, Q., Zhang, B.,... Zheng, W. (2016). Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry. Cancer Causes & Control, 27(5), 679-93.
Ghoussaini, M., French, J.D., Michailidou, K., Nord, S., Beesley, J., Canisus, S.,... Edwards, S.L. (2016). Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation. American Journal of Human Genetics, 99(4), 903-911.
Horne, H.N., Chung, C.C., Zhang, H., Yu, K., Prokunina-Olsson, L., Michailidou, K.,... Figueroa, J.D. (2016). Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus. PLoS ONE, 11(8).

Last updated on 2016-10-05 at 08:26